Ant Ayca, Yazici Ömer, Atabey Pinar, Aslan Ferit Ferhat, Duran Arzubetul, Ozlugedik Samet, Kemaloglu Yusuf Kemal
Department of Otorhinolaryngology, Head and Neck Surgery, University of Medical Sciences, Ankara A.Y. Oncology Education and Research Hospital, Yenimahalle, 06200, Ankara, Turkey.
Department of Radiation Oncology, University of Medical Sciences, Ankara A.Y. Oncology Education and Research Hospital, Ankara, Turkey.
Eur Arch Otorhinolaryngol. 2019 Apr;276(4):977-984. doi: 10.1007/s00405-019-05299-7. Epub 2019 Jan 22.
This study analyzed the late ear complications of radiotherapy for nasopharyngeal cancer (NPC) and compared the conventional and intensity-modulated radiotherapy (2D-RT and IMRT, respectively).
At 2-21 years after the end of NPC treatment, 104 ears of 52 patients were evaluated with the otoscopic examination, pure tone audiometry test, tympanometry, and subjective complaints by being blinded to the radiotherapy technique.
There were no differences in terms of the pathology of the external, middle or inner ear, air and bone-conduction hearing thresholds, and the air-bone (A-B) gap at 500, 1000, 2000, and 4000 Hz, and tympanometry types between 2D-RT and IMRT groups (p > 0.05). There were positive correlations between the values of A500 and A1000 thresholds; gap 500, 4000, and mean cochlear RT dose (p < 0.05). There were positive correlations between the values of A500, A1000, and A4000 thresholds; gap 500, 1000, 2000, 4000, and maximum cochlear RT dose (p < 0.05).
IMRT was not found to be superior to 2D-RT to prevent RT-induced ear complications. The solution of the middle ear problems must be the goal of the strategies for complications treatment.
本研究分析了鼻咽癌(NPC)放疗后的晚期耳部并发症,并比较了传统放疗和调强放疗(分别为2D-RT和IMRT)。
在NPC治疗结束后2至21年,对52例患者的104只耳朵进行了耳镜检查、纯音听力测试、鼓室图检查,并在不了解放疗技术的情况下收集主观症状。
2D-RT组和IMRT组在外耳、中耳或内耳的病理、气导和骨导听力阈值、500、1000、2000和4000Hz的气骨(A-B)间隙以及鼓室图类型方面均无差异(p>0.05)。A500和A1000阈值的值与500、4000间隙以及平均耳蜗放疗剂量之间存在正相关(p<0.05)。A500、A1000和A4000阈值的值与500、1000、2000、4000间隙以及最大耳蜗放疗剂量之间存在正相关(p<0.05)。
未发现IMRT在预防放疗引起的耳部并发症方面优于2D-RT。解决中耳问题必须是并发症治疗策略的目标。